CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly licensed Geenius test is an immunochromatographic assay designed to confirm and differentiate individual antibodies to Human Immunodeficiency Virus Types 1 and 2. The assay will be replacing the HIV-1 Western blot and HIV-2 EIA assays which are performed on samples with a reactive result on a licensed HIV 1/2 screening test.
Read all about it on the Communication page by clicking this link: Communications
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...
CTS will implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The ...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...